Gian Lifecare Ltd
Incorporated in 2018, Kanpur (UP) based Gian Life Care Limited is engaged in the business of providing diagnostic and related healthcare services. The company caters to individual patients, hospitals, corporates and other healthcare providers.
- Market Cap ₹ 20.6 Cr.
- Current Price ₹ 19.9
- High / Low ₹ 29.0 / 18.2
- Stock P/E 19.4
- Book Value ₹ 15.1
- Dividend Yield 0.00 %
- ROCE 11.3 %
- ROE 7.27 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -3.26%
- Promoters have pledged 26.5% of their holding.
- Debtor days have increased from 70.8 to 99.5 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | TTM | |
|---|---|---|---|
| 15.45 | 11.92 | 10.07 | |
| 9.39 | 10.09 | 7.79 | |
| Operating Profit | 6.06 | 1.83 | 2.28 |
| OPM % | 39.22% | 15.35% | 22.64% |
| 0.51 | 0.69 | 0.66 | |
| Interest | 0.39 | 0.43 | 0.48 |
| Depreciation | 0.33 | 0.50 | 0.54 |
| Profit before tax | 5.85 | 1.59 | 1.92 |
| Tax % | 25.30% | 33.33% | |
| 4.37 | 1.06 | 1.06 | |
| EPS in Rs | 4.23 | 1.02 | 1.02 |
| Dividend Payout % | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Sep 2023 | |
|---|---|---|---|
| Equity Capital | 10.34 | 10.34 | 10.34 |
| Reserves | 3.69 | 4.78 | 5.24 |
| 2.03 | 4.58 | 1.39 | |
| 7.00 | 8.54 | 13.31 | |
| Total Liabilities | 23.06 | 28.24 | 30.28 |
| 3.50 | 4.61 | 4.37 | |
| CWIP | 0.12 | 0.14 | 0.14 |
| Investments | 0.00 | 0.00 | 0.00 |
| 19.44 | 23.49 | 25.77 | |
| Total Assets | 23.06 | 28.24 | 30.28 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| 5.79 | 2.22 | |
| -4.12 | -0.94 | |
| 0.67 | -0.37 | |
| Net Cash Flow | 2.34 | 0.91 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | |
|---|---|---|
| Debtor Days | 42.05 | 99.52 |
| Inventory Days | 116.38 | |
| Days Payable | 380.87 | |
| Cash Conversion Cycle | 42.05 | -164.98 |
| Working Capital Days | -31.66 | -64.92 |
| ROCE % |
Documents
Announcements
- Compliance Under Reg 40(10) 30 Apr
- Compliance Certificate For The Period Ended March 31, 2024 30 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
22 Apr - Certificate under Regulation 74(5). For Gian Life Care Limited
- Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015 2 Apr
- Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015 4 Mar
Annual reports
Concalls
-
Nov 2021TranscriptNotesPPT
Business Overview:[1]
Company provides diagnostic and related
healthcare tests and services in Kanpur
and nearby areas. Company provides diagnostic and related healthcare tests and services viz. patient diagnosis, prevention and wellness diagnosis services to its patients and healthcare providers. Company is in process to open several diagnostics labs in various parts of country. Another major lab in Lucknow also became operational in April, 2022